MedTech News

Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ — EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world’s first anti-nausea smart watch.

J&J’s DePuy Synthes launches new plating system
J&J MedTech’s (NYSE: JNJ)+
DePuy Synthes unit today announced that it launched its TriLeap lower extremity anatomic plating system.

Pulse Biosciences touts first-in-human pulsed field ablation cases
Pulse Biosciences (Nasdaq:PLSE) today announced the first completed cases in a first-in-human feasibility study of its pulsed field ablation system.

U.S. Food and Drug Administration Gives Huxley Medical 510(k) Clearance for SANSA Home Sleep Apnea Test
ATLANTA, Aug. 7, 2024 /PRNewswire/ — Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking, chest-worn, sleep apnea diagnostic patch, SANSA.

Natus introduces autoSCORE, an innovative AI solution capable of a new era of expert-level clinical EEG interpretation
MIDDLETON, Wis., Aug. 7, 2024 /PRNewswire/ — Natus Medical Incorporated has announced the launch of autoSCORE, the first-of-its-kind artificial intelligence model capable of automatic and comprehensive clinical EEG interpretation, providing accuracy on par with medical experts.

How supercharged silk could help heal the heart
UNSW researchers have developed a new microgel made of moth silk that is designed to assist with tissue regeneration and could help people recover from heart attacks.

Electric bandage holds promise for treating chronic wounds
Researchers have developed an inexpensive bandage that uses an electric field to promote healing in chronic wounds

Researchers develop a new vaccine additive that creates a stronger, tunable immune response
Researchers at Stanford Engineering have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV.